Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04826003
Title Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | GBR | ESP | DNK

Facility Status City State Zip Country Details
Rigshospitalet; Fase 1 Enhed - Onkologi København Ø 2100 Denmark Details
Severance Hospital, Yonsei University Health System Seoul 03722 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
NKI/AvL Amsterdam 1066 CX Netherlands Details
Clinica Universitaria de Navarra; Servicio de Oncologia Pamplona Navarra 31008 Spain Details
Hospital del Mar; Servicio de Oncologia Barcelona 08003 Spain Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Clinica Universidad de Navarra Madrid; Servicio de Oncología Madrid 28027 Spain Details
Fundacion Jimenez Diaz; Servicio de Oncologia Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre; Servicio de Oncologia Madrid 28041 Spain Details
Centro Integral Oncologico Clara Campal; Servicio de Oncología Madrid 28050 Spain Details
Christie Hospital NHS Trust; Experimental Cancer Medicine Team Manchester M20 4BX United Kingdom Details
Churchill Hospital Oxford OX3 7LJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field